Quick Answer
CRYO CELL INTERNATIONAL INC reported Total Revenue of $25.38 million for fiscal year 2017.
CRYO CELL INTERNATIONAL INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$2.43M -704.2% |
$402.1K +104.2% |
-$9.52M -443.6% |
$2.77M +33.0% |
$2.08M -42.5% |
$3.62M +58.2% |
| Diluted EPS | -$0.30 -700.0% |
$0.05 +104.4% |
-$1.14 -445.5% |
$0.33 +32.0% |
$0.25 -44.4% |
$0.45 +66.7% |
| Total Assets | $61.73M -4.6% |
$64.68M +5.6% |
$61.22M -5.7% |
$64.89M +7.0% |
$60.66M +31.3% |
$46.20M +7.7% |
| Cash and Equivalents | $319.0K -43.1% |
$561.0K +38.1% |
$406.1K -76.2% |
$1.70M -79.4% |
$8.26M -20.2% |
$10.36M +58.4% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | -$18.61M -40.8% |
-$13.22M -19.8% |
-$11.03M -623.7% |
-$1.52M -136.4% |
$4.18M +257.0% |
-$2.67M +61.7% |
| R&D Expense | $376.3K -69.7% |
$1.24M +6.1% |
$1.17M +204.4% |
$384.8K +671.6% |
$49.9K +109.1% |
$23.9K -20.9% |
| Operating Income | $482.4K -86.1% |
$3.48M +128.3% |
-$12.30M -405.7% |
$4.02M +0.2% |
$4.02M -47.6% |
$7.66M +51.3% |
| Shares Outstanding | 8.06M -0.3% |
8.08M -2.5% |
8.29M -2.5% |
8.50M -0.6% |
8.55M +13.3% |
7.55M +0.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | May 31, 2018 | $6.53M | +4.6% | +4.8% |
| Net Income | August 31, 2025 | $749.4K | -28.7% | +110.6% |
| Diluted EPS | August 31, 2025 | $0.09 | -30.8% | +125.0% |
| Total Assets | August 31, 2025 | $63.17M | +0.4% | -2.0% |
| Cash and Equivalents | August 31, 2025 | $265.2K | +34.3% | +92.9% |
| Long-Term Debt | May 31, 2019 | $1.43M | +0.0% | +0.0% |
| Stockholders Equity | August 31, 2025 | -$14.83M | -55.2% | +4.7% |
| R&D Expense | August 31, 2025 | $61.6K | -68.2% | -53.2% |
| Operating Income | August 31, 2025 | $1.90M | +36.7% | +27.3% |
| Shares Outstanding | August 31, 2025 | 8.06M | -0.1% | -0.1% |
- CRYO CELL INTERNATIONAL INC reported Total Revenue of $25.38 million for fiscal year 2017.
- CRYO CELL INTERNATIONAL INC showed an increase of +9.8% in Total Revenue compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Net Income of -$2.43 million for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -704.2% in Net Income compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Diluted EPS of $0.30 per share (loss) for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -700.0% in Diluted EPS compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Total Assets of $61.73 million for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -4.6% in Total Assets compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Cash and Equivalents of $319.0 thousand for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -43.1% in Cash and Equivalents compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Long-Term Debt of $1.43 million for fiscal year 2018.
- CRYO CELL INTERNATIONAL INC showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Stockholders Equity of -$18.61 million for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -40.8% in Stockholders Equity compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported R&D Expense of $376.3 thousand for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -69.7% in R&D Expense compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Operating Income of $482.4 thousand for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -86.1% in Operating Income compared to the prior fiscal year.
- CRYO CELL INTERNATIONAL INC reported Shares Outstanding of 8.06 million shares for fiscal year 2025.
- CRYO CELL INTERNATIONAL INC showed a decrease of -0.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: